نویسنده: دکتر هادی انصاری هادی پور
16 مارس 10
| رتبه در سال 2006 | نام شرکت | کشور | درآمد کل در سال 2006 (میلیون دلار آمریکا) | هزینه تحقیق و توسعه در سال 2006 (میلیون دلار آمریکا) | درآمد خالص/(ضرر) در سال 2006(میلیون دلار آمریکا) | تعداد کارمندان در سال 2006 |
| 1 | Amgen | USA | 14,268.0 | 3,366.0 | 2,950.0 | 20,100 |
| 2 | Genentech | USA | 9,284.0 | 1,773.0 | 2,113.0 | 10,533 |
| 3 | Genzyme | USA | 3,187.0 | 650.0 | (16.8) | 9,000+ |
| 4 | UCB | Belgium | 3,169.6 | 772.6 | 461.1 | 8,477 |
| 5 | Gilead Sciences | USA | 3,026.1 | 383.9 | (1,190.0) | 7,575 |
| 6 | Serono | Switzerland | 2,804.9 | 560.5 | 735.4 | 4,775 |
| 7 | Biogen Idec | USA | 2,683.0 | 718.4 | 217.5 | 3,750 |
| 8 | CSL | Australia | 2,148.3 | 119.1 | 86.8 | 2,895 |
| 9 | Cephalon | USA | 1,764.1 | 403.4 | 144.8 | 2,515 |
| 10 | MedImmune | USA | 1,276.8 | 448.9 | 48.7 | 2,359 |
| 11 | Celgene | USA | 898.9 | 258.6 | 69.0 | 1,864 |
| 12 | Abraxis BioScience | USA | 765.5 | 96.9 | (46.9) | 1,734 |
| 13 | Actelion | Switzerland | 754.6 | 169.0 | 192.4 | 1,550 |
| 14 | ImClone Systems | USA | 677.8 | 112.1 | 370.7 | 1,287 |
| 16 | Amylin Pharmaceuticals | USA | 510.9 | 222.1 | (218.9) | 1,100 |
| 17 | Millennium Pharmaceuticals | USA | 486.8 | 318.2 | (44.0) | 1,073 |
| 18 | PDL BioPharma | USA | 414.8 | 260.7 | (130.0) | 993 |
| 19 | OSI Pharmaceuticals | USA | 375.7 | 176.7 | (582.2) | 962 |
| 20 | MGI Pharma | USA | 342.8 | 100.1 | (40.2) | 947 |
| 21 | Pharmion | USA | 238.6 | 70.1 | (91.0) | 793 |
| 22 | Nektar Therapeutics | USA | 217.7 | 149.4 | (154.8) | 770 |
| 23 | Vertex Pharmaceuticals | USA | 216.4 | 371.7 | (206.9) | 760 |
| 24 | Biocon | India | 200.3 | 30.5 | 43.5 | 1,838 |
| 25 | Cubist Pharmaceuticals | USA | 194.7 | 57.4 | (0.4) | 746 |
| 26 | Enzon Pharmaceuticals | USA | 185.7 | 43.5 | 21.3 | 722 |
| 27 | QLT | Canada | 175.1 | 56.4 | (101.6) | 653 |
| 28 | ViroPharma | USA | 167.2 | 19.2 | 66.7 | 651 |
| 29 | Alkermes | USA | 166.6 | 89.1 | 3.8 | 617 |
| 30 | Crucell | Netherlands | 165.3 | 84.9 | (110.0) | 611 |
| 31 | United Therapeutics | USA | 159.6 | 57.6 | 74.0 | 585 |
| 32 | LifeCell | USA | 141.7 | 16.5 | 20.5 | 573 |
| 33 | Ligand Pharmaceuticals | USA | 141.0 | 41.9 | (31.7) | 540 |
| 34 | Myriad Genetics | USA | 114.3 | 83.8 | (38.2) | 511 |
| 35 | Exelixis | USA | 98.7 | 185.5 | (101.5) | 500 |
| 36 | Cangene | Canada | 96.8 | 22.1 | 11.6 | 498 |
| 37 | InterMune | USA | 90.8 | 103.8 | (107.2) | 492 |
| 38 | Nabi Biopharmaceuticals | USA | 89.9 | 37.6 | (58.7) | 487 |
| 39 | BioMarin Pharmaceutical | USA | 84.2 | 66.7 | (28.5) | 417 |
| 40 | Lexicon Pharmaceuticals | USA | 72.8 | 106.7 | (54.3) | 410 |
| 41 | Progenics Pharmaceuticals | USA | 69.9 | 61.7 | (21.6) | 410 |
| 42 | Innogenetics | Belgium | 67.5 | 32.1 | (31.5) | 371 |
| 43 | Idenix Pharmaceuticals | USA | 67.4 | 96.1 | (75.1) | 359 |
| 44 | MorphoSys | Germany | 66.6 | 21.9 | 7.6 | 336 |
| 45 | Omrix Biopharmaceuticals | USA | 63.8 | 3.4 | 23.1 | 335 |
| 46 | Regeneron Pharmaceuticals | USA | 63.4 | 137.1 | (102.3) | 323 |
| 47 | Acambis | UK | 57.0 | 68.2 | (30.4) | 285 |
| 48 | Tanox | USA | 56.1 | 53.4 | (2.6) | 285 |
| 49 | ViaCell | USA | 54.4 | 14.0 | (21.0) | 282 |
| 50 | Indevus Pharmaceuticals | USA | 50.5 | 43.2 | -50.6 | 279 |
| 51 | Medarex | USA | 48.6 | 194.5 | (181.7) | 277 |
| 52 | NPS Pharmaceuticals | USA | 48.5 | 68.4 | (112.7) | 276 |
| 53 | Monogram Biosciences | USA | 48.0 | 19.0 | (38.7) | 274 |
| 54 | Oscient Pharmaceuticals | USA | 46.2 | 12.4 | (78.5) | 267 |
| 55 | Array BioPharma | USA | 45.0 | 33.4 | (39.6) | 263 |
| 56 | AEterna Zentaris | Canada | 41.4 | 28.7 | 33.4 | 260 |
| 57 | IsoTis | Switzerland | 40.7 | 7.7 | (18.5) | 255 |
| 58 | Enzo Biochem | USA | 39.8 | 7.9 | (15.7) | 255 |
| 59 | CuraGen | USA | 39.6 | 58.5 | (59.8) | 254 |
| 60 | Neurocrine Biosciences | USA | 39.2 | 97.7 | (107.2) | 254 |
| 61 | MediGene | Germany | 38.4 | 26.7 | (8.7) | 248 |
| 62 | Life Therapeutics | Australia | 37.6 | 0.1 | (31.2) | 245 |
| 63 | Inspire Pharmaceuticals | USA | 37.1 | 42.5 | (42.1) | 238 |
| 64 | CV Therapeutics | USA | 36.8 | 135.3 | (274.3) | 233 |
| 65 | Cerus | USA | 35.6 | 29.5 | (4.8) | 208 |
| 66 | SciClone Pharmaceuticals | USA | 32.7 | 14.1 | 0.7 | 197 |
| 67 | ImmunoGen | USA | 32.1 | 40.9 | (17.8) | 197 |
| 68 | Protherics | UK | 30.9 | 11.8 | (16.5) | 196 |
| 69 | Arena Pharmaceuticals | USA | 30.6 | 103.4 | (88.3) | 195 |
| 70 | Vernalis | UK | 30.1 | 71.7 | (78.2) | 192 |
| 71 | Bavarian Nordic | Denmark | 29.5 | 19.9 | (27.1) | 191 |
| 72 | Xoma | USA | 29.5 | 52.1 | (51.8) | 189 |
| 73 | GPC Biotech | Germany | 28.5 | 81.3 | (80.4) | 180 |
| 74 | Micromet | USA | 27.6 | 28.3 | 0.0 | 171 |
| 75 | Targacept | USA | 27.5 | 21.8 | (1.2) | 170 |
| 76 | Carrington Laboratories | USA | 27.4 | 5.8 | (7.6) | 166 |
| 77 | Acorda Therapeutics | USA | 27.4 | 12.1 | (60.0) | 158 |
| 78 | Anika Therapeutics | USA | 26.8 | 3.6 | 4.6 | 156 |
| 79 | Human Genome Sciences | USA | 25.8 | 209.2 | (251.2) | 151 |
| 80 | Dusa Pharmaceuticals | USA | 25.6 | 6.2 | (31.3) | 150 |
| 81 | ZymoGenetics | USA | 25.4 | 128.5 | (130.0) | 150 |
| 82 | Maxygen | USA | 25.0 | 49.1 | (16.5) | 147 |
| 83 | Isis Pharmaceuticals | USA | 24.5 | 80.6 | (45.9) | 133 |
| 84 | Genmab | Denmark | 23.9 | 90.6 | (77.4) | 128 |
| 85 | Bioniche Life Sciences | Canada | 23.9 | 11.6 | (1.0) | 126 |
| 86 | Vitrolife | Sweden | 23.2 | 3.3 | 2.1 | 124 |
| 87 | Coley Pharmaceutical Group | USA | 20.2 | 40.9 | (29.4) | 122 |
| 88 | Palatin Technologies | USA | 19.7 | 41.0 | (29.0) | 116 |
| 89 | Encysive Pharmaceuticals | USA | 19.0 | 64.4 | (109.3) | 109 |
| 90 | GenVec | USA | 18.9 | 29.6 | (19.3) | 95 |
| 91 | Medivir Group | Sweden | 18.8 | 39.7 | (29.7) | 88 |
| 92 | Peptech | Australia | 18.7 | 4.6 | 3.8 | 85 |
| 93 | Ambrilia Biopharma | Canada | 17.4 | 8.3 | (2.1) | 85 |
| 94 | Cytogen | USA | 17.3 | 7.3 | (15.1) | 85 |
| 95 | Replidyne | USA | 16.0 | 38.3 | (34.6) | 79 |
| 96 | Sinovac Biotech | China | 15.4 | 0.3 | (0.7) | 67 |
| 97 | Trimeris | USA | 15.2 | 18.3 | 7.4 | 64 |
| 98 | Avanir Pharmaceuticals | USA | 15.2 | 29.2 | (62.6) | 64 |
| 99 | Adolor | USA | 15.1 | 56.7 | (69.7) | 51 |
| 100 | JN-International Medical Corporation | USA | 9.6 | 24.3 | 4.8 | 15 |
نظر دهید
۰
